Scientists at the University of California San Diego have developed a mosquito suppression system, Ifegenia, that uses CRISPR technology to eliminate females Anopheles gambiae mosquitoes, the main transmitters of malaria in Africa. The system disrupts a gene that controls the sexual development of mosquitoes, thus halting the spread of the disease. The researchers are optimistic that this approach, which is safe, controllable and scalable, can be adapted to suppress other disease-spreading species.
As expected, this first-of-its-kind African mosquito suppression system would reduce infant mortality and aid economic development.
Malaria remains one of the deadliest diseases in the world. Malaria infections cause hundreds of thousands of deaths each year, with the majority of deaths occurring in children under five. The Centers for Disease Control and Prevention recently announced that there have been five cases of mosquito-borne malaria in the United States (four in Florida and one in Texas, the first reported outbreak in the country in two decades.
Fortunately, scientists are developing safe technologies to stop malaria transmission by genetically modifying mosquitoes that spread the disease-causing parasite. Researchers at the University of California San Diego led by the laboratory of Professor Omar Akbaris have designed a new way to genetically suppress populations of Anopheles gambiae, the mosquitoes that primarily spread malaria in Africa and contribute to economic poverty in affected regions. The new system targets and kills female del A. gambie population as they bite and spread disease.
UC San Diego researchers have developed new technology to suppress Anopheles gambiae, the mosquitoes that primarily spread malaria in Africa and contribute to economic poverty in affected regions. Credit: Akbari Lab, UC San Diego
Published July 5 in the magazine
Scientists at UC Berkeley and the California Institute of Technology contributed to the research effort.
This technology has the potential to be the safe, controllable and scalable solution the world urgently needs to eliminate malaria once and for all.
Omar Akbari, Professor in the Department of Cell and Developmental Biology
Ifegenia works by genetically encoding the two main elements of CRISPR within African mosquitoes. These include a Cas9 nuclease, the molecular scissors that make the cuts and a guide RNA that directs the system to the target through a technique developed in these mosquitoes in Akbaris lab. They genetically modified two mosquito families to separately express Cas9 and the fle-targeting guide RNA.
An artists depiction of Ifegenia, a new technology developed at UC San Diego that uses CRISPR genetic editing to disrupt a gene that controls sexual development in the larva of African mosquitoes. Credit: Reema Apte
We crossed them together and in the offspring, it killed all the female mosquitoes, said Smidler, it was extraordinary. Meanwhile, A. gambiae male mosquitoes inherit Ifegenia but the genetic edit doesnt impact their reproduction. They remain reproductively fit to mate and spread Ifegenia. Parasite spread eventually is halted since females are removed and the population reaches a reproductive dead end. The new system, the authors note, circumvents certain genetic resistance roadblocks and control issues faced by other systems such as gene drives since the Cas9 and guide RNA components are kept separate until the population is ready to be suppressed.
We show that Ifegenia males remain reproductively viable, and can load both fle mutations and CRISPR machinery to induce fle mutations in subsequent generations, resulting in sustained population suppression, the authors note in the paper. Through modeling, we demonstrate that iterative releases of non-biting Ifegenia males can act as an effective, confinable, controllable, and safe population suppression and elimination system.
Larva of Anopheles gambiae mosquitoes were injected with CRISPR-based genetic editing tools in a new population suppression system. Credit: Akbari Lab, UC San Diego
Traditional methods to combat malaria spread such as bed nets and insecticides increasingly have been proven ineffective in stopping the diseases spread. Insecticides are still heavily used across the globe, primarily in an effort to stop malaria, which increases health and ecological risks to areas in Africa and Asia.
Smidler, who earned a PhD (biological sciences of public health) from Harvard University before joining UC San Diego in 2019, is applying her expertise in genetic technology development to address the spread of the disease and the economic harm that comes with it. Once she and her colleagues developed Ifegenia, she was surprised by how effective the technology worked as a suppression system.
Ifegenia technology study first author Andrea Smidler (left) and co-first author Reema Apte. Credit: Akbari Lab, UC San Diego
This technology has the potential to be the safe, controllable, and scalable solution the world urgently needs to eliminate malaria once and for all, said Akbari, a professor in the Department of Cell and Developmental Biology. Now we need to transition our efforts to seek social acceptance, regulatory use authorizations, and funding opportunities to put this system to its ultimate test of suppressing wild malaria-transmitting mosquito populations. We are on the cusp of making a major impact in the world and wont stop until thats achieved.
The researchers note that the technology behind Ifegenia could be adapted to other species that spread deadly diseases, such as mosquitoes known to transmit dengue (break-bone fever), chikungunya, and yellow fever viruses.
Reference: A confinable female-lethal population suppression system in the malaria vector, Anopheles gambiae by Andrea L. Smidler, James J. Pai, Reema A. Apte, Hctor M. Snchez C., Rodrigo M. Corder, Eileen Jeffrey Gutirrez, Neha Thakre, Igor Antoshechkin, John M. Marshall and Omar S. Akbari, 5 July 2023, Science Advances.
DOI: 10.1126/sciadv.ade8903
The full author list includes Andrea Smidler, James Pai, Reema Apte, Hector Sanchez C., Rodrigo Corder, Eileen Jeffrey Gutierrez, Neha Thakre, Igor Antoshechkin, John Marshall, and Omar Akbari.
Funding for the research was provided by: a DARPA Safe Genes Program Grant (HR0011-17-2-0047), a National Institutes of Health award (R01AI151004), and the Bill and Melinda Gates Foundation (INV-017683).
#BuzzOff #gene #technology #developed #stop #mosquitoes #spreading #malaria
Image Source : scitechdaily.com